Page last updated: 2024-10-26

valproic acid and Achromatopsia

valproic acid has been researched along with Achromatopsia in 2 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Achromatopsia: Severely deficient color perception, typically with monochromacy and reduced visual acuity. The atypical form can include normal visual acuity with pseudomonochromacy.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lobefalo, L1
Rapinese, M1
Altobelli, E1
Di Mascio, R1
Lattanzi, D1
Gallenga, PE1
Chiarelli, F1
Verrotti, A1
López, L1
Thomson, A1
Rabinowicz, AL1

Other Studies

2 other studies available for valproic acid and Achromatopsia

ArticleYear
Retinal nerve fiber layer and macular thickness in adolescents with epilepsy treated with valproate and carbamazepine.
    Epilepsia, 2006, Volume: 47, Issue:4

    Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Color Vision Defects; Epilepsy; Female; Follow-Up

2006
Assessment of colour vision in epileptic patients exposed to single-drug therapy.
    European neurology, 1999, Volume: 41, Issue:4

    Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Color Perception; Color Vision Defects; Dip

1999